Comparison of PNA clamping and direct sequencing for detecting KRAS mutations in matched tumour tissue, cell block, pleural effusion and serum from patients with malignant pleural effusion. Issue 1 (9th October 2014)
- Record Type:
- Journal Article
- Title:
- Comparison of PNA clamping and direct sequencing for detecting KRAS mutations in matched tumour tissue, cell block, pleural effusion and serum from patients with malignant pleural effusion. Issue 1 (9th October 2014)
- Main Title:
- Comparison of PNA clamping and direct sequencing for detecting KRAS mutations in matched tumour tissue, cell block, pleural effusion and serum from patients with malignant pleural effusion
- Authors:
- Kang, Ji Young
Park, Chan Kwon
Yeo, Chang Dong
Lee, Hea Yeon
Rhee, Chin Kook
Kim, Seung Joon
Kim, Seok Chan
Kim, Young Kyoon
Park, Mi Sun
Yim, Hyeon Woo - Abstract:
- <abstract abstract-type="main"> <title>Abstract</title> <sec id="resp12413-sec-0001" sec-type="section"> <title>Background and objective</title> <p>Peptide nucleic acid (PNA)‐mediated real‐time polymerase chain reaction clamping was recently developed to improve mutation detection sensitivity. Pleural effusion could be a good sample candidate for mutation analysis. To establish if PNA clamping could be used to detect <italic>KRAS</italic> mutation in particular in pleural effusion, we analysed its diagnostic performance.</p> </sec> <sec id="resp12413-sec-0002" sec-type="section"> <title>Methods</title> <p>We studied 57 patients with malignant effusion. <italic>KRAS</italic> mutation was evaluated in samples of matched tumour tissue, cell block, pleural effusion and serum using PNA clamping and direct sequencing.</p> </sec> <sec id="resp12413-sec-0003" sec-type="section"> <title>Results</title> <p>The detection rate of <italic>KRAS</italic> mutation using pleural effusion was 14% for PNA clamping and 10.5% for direct sequencing. The κ coefficient between the two methods was 0.76 (<italic>P</italic> value &lt; 0.0001), 1.00 (<italic>P</italic> value &lt; 0.0001) and 0.87 (<italic>P</italic> value &lt; 0.0001) in pleural effusion, tissue and cell block, respectively. The diagnostic performance of <italic>KRAS</italic> mutation detection from pleural effusion compared with the results obtained for all samples combined showed that the sensitivity, specificity, positive predictive<abstract abstract-type="main"> <title>Abstract</title> <sec id="resp12413-sec-0001" sec-type="section"> <title>Background and objective</title> <p>Peptide nucleic acid (PNA)‐mediated real‐time polymerase chain reaction clamping was recently developed to improve mutation detection sensitivity. Pleural effusion could be a good sample candidate for mutation analysis. To establish if PNA clamping could be used to detect <italic>KRAS</italic> mutation in particular in pleural effusion, we analysed its diagnostic performance.</p> </sec> <sec id="resp12413-sec-0002" sec-type="section"> <title>Methods</title> <p>We studied 57 patients with malignant effusion. <italic>KRAS</italic> mutation was evaluated in samples of matched tumour tissue, cell block, pleural effusion and serum using PNA clamping and direct sequencing.</p> </sec> <sec id="resp12413-sec-0003" sec-type="section"> <title>Results</title> <p>The detection rate of <italic>KRAS</italic> mutation using pleural effusion was 14% for PNA clamping and 10.5% for direct sequencing. The κ coefficient between the two methods was 0.76 (<italic>P</italic> value &lt; 0.0001), 1.00 (<italic>P</italic> value &lt; 0.0001) and 0.87 (<italic>P</italic> value &lt; 0.0001) in pleural effusion, tissue and cell block, respectively. The diagnostic performance of <italic>KRAS</italic> mutation detection from pleural effusion compared with the results obtained for all samples combined showed that the sensitivity, specificity, positive predictive value and negative predictive value were as follows: 89, 100, 100 and 98%, respectively for PNA clamping; 67, 100, 100 and 94%, respectively for directing sequencing.</p> </sec> <sec id="resp12413-sec-0004" sec-type="section"> <title>Conclusions</title> <p>The current study suggests that PNA clamping had a good concordance with direct sequencing for the detection of <italic>KRAS</italic> mutation in patients with malignant effusion. Furthermore, the good diagnostic performance obtained from pleural effusion samples provides evidence that pleural effusion can be a useful source for detecting <italic>KRAS</italic> mutation in a clinical setting, in which the collection of tumour tissues is challenging.</p> </sec> </abstract> … (more)
- Is Part Of:
- Respirology. Volume 20:Issue 1(2015)
- Journal:
- Respirology
- Issue:
- Volume 20:Issue 1(2015)
- Issue Display:
- Volume 20, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 20
- Issue:
- 1
- Issue Sort Value:
- 2015-0020-0001-0000
- Page Start:
- 138
- Page End:
- 146
- Publication Date:
- 2014-10-09
- Subjects:
- Respiratory organs -- Diseases -- Periodicals
Respiratory organs -- Periodicals
612.2 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=res ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/resp.12413 ↗
- Languages:
- English
- ISSNs:
- 1323-7799
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7777.666000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3126.xml